glp-1 and gip/glp-1 medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica DID YOU KNOW? GLP-1 medications

Liraglutide also carries warnings about pancreatitis, liraglutide pen sharing, hypoglycemia when used in conjunction with certain other drugs known to cause hypoglycemia including insulin and sulfonylurea, renal impairment or kidney failure, hypersensitivity and acute gallbladder disease

The 39-amino acid chain is longer than most therapeutic peptides

Sequences containing NEP-24.11 cleavage sites were filtered out to enhance stability

Key agents include albiglutide, dulaglutide, exenatide, liraglutide, and semaglutide

10.1172/JCI43703 [DOI] [PMC free article] [PubMed] [Google Scholar] Scrocchi, L

The rats were provided with ad libitum access to food and water and were kept on a 12 h light/12 h dark cycle